Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Alexandria Real Estate Equities Inc. Stock Slides 5.4%, Underperforms Peers

Alexandria Real Estate Equities Inc. Stock Slides 5.4%, Underperforms Peers

Dow JonesDow Jones2026/09/18 20:33

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Alexandria Real Estate Equities Inc. slipped 5.4% to $53.30 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.2% to 7,650.50 and the Dow Jones Industrial Average falling 0.2% to 51,682.64.

The stock's fall snapped a five-day winning streak.

Alexandria Real Estate Equities Inc. closed 39.6% short of its 52-week high of $88.24, which the company reached on September 19th.

The stock demonstrated a mixed performance when compared to some of its peers, as BXP Inc. fell 1.2% to $63.17, Healthpeak Properties Inc. fell 0.8% to $20.33, and Medical Properties Trust Inc. fell 5.56% to $3.40.

Trading volume totaled 4.1 million, compared to the 50-day average of 1.9 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 18, 2026 16:33 ET (20:33 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity

Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

智通财经•2026/11/12 01:01
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity